T. Rowe Price Associates’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.69M Buy
31,901
+1,075
+3% +$56.8K ﹤0.01% 1716
2025
Q1
$1.72M Buy
30,826
+1,098
+4% +$61.1K ﹤0.01% 1676
2024
Q4
$1.29M Sell
29,728
-3,358
-10% -$145K ﹤0.01% 1857
2024
Q3
$1.7M Buy
33,086
+2,697
+9% +$138K ﹤0.01% 1715
2024
Q2
$1.92M Buy
30,389
+1,593
+6% +$101K ﹤0.01% 1570
2024
Q1
$1.91M Buy
28,796
+1,353
+5% +$89.6K ﹤0.01% 1586
2023
Q4
$2.7M Buy
27,443
+1,064
+4% +$105K ﹤0.01% 1410
2023
Q3
$2.11M Sell
26,379
-98,432
-79% -$7.89M ﹤0.01% 1436
2023
Q2
$10.1M Sell
124,811
-102,664
-45% -$8.29M ﹤0.01% 1077
2023
Q1
$27.7M Sell
227,475
-77,251
-25% -$9.39M ﹤0.01% 836
2022
Q4
$40.6M Sell
304,726
-81,622
-21% -$10.9M 0.01% 722
2022
Q3
$43.1M Buy
386,348
+9,797
+3% +$1.09M 0.01% 689
2022
Q2
$51.1M Buy
376,551
+355,127
+1,658% +$48.2M 0.01% 864
2022
Q1
$3.57M Buy
21,424
+2,136
+11% +$356K ﹤0.01% 1526
2021
Q4
$3.45M Sell
19,288
-704
-4% -$126K ﹤0.01% 1556
2021
Q3
$3.54M Sell
19,992
-990
-5% -$175K ﹤0.01% 1561
2021
Q2
$3.37M Sell
20,982
-1,562
-7% -$251K ﹤0.01% 1586
2021
Q1
$3.38M Buy
22,544
+2,287
+11% +$342K ﹤0.01% 1556
2020
Q4
$2M Buy
+20,257
New +$2M ﹤0.01% 1634